Glenmark Life Sciences Limited

NSE: GLS BSE: 543322 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1060 9(-1%)

Volume

1L as on 19, Jun

Open

1,065

High

1,074

Low

1,052

1,069

VWAP

1,070

52 Week High

1,335

52 Week Low

819

Viand Research Rating

Quality Score

0/100

Growth Score

0/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

13,307

No. of Shares

12.3

P/E

31.38

P/B

5.23

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

16.68

ROCE

Profit Growth

Listing Date

06-Aug-21

Promoter Holding

74.91%

FII Holding

5.08%

DII Holding

7.13%

Price Chart

Price Performance

1 Week2%

1 Month1%

3 Months15%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA1,055

10 Day SMA1,041

20 Day SMA1,046

30 Day SMA1,056

50 Day SMA1,057

61 Day SMA1,043

80 Day SMA1,089

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,085	1,065	1,074	1,084
Resistance 2	1,074	1,063	1,068	1,074
Resistance 1	1,067	1,062	1,064	1,067
Pivot Point	1,057	1,060	1,057	1,057
Support 1	1,050	1,058	1,050	1,049
Support 2	1,039	1,057	1,046	1,039
Support 3	1,032	1,055	1,039	1,032

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 74.91%	(0.01) 74.91%	(0.01) 74.94%	(0.01) 74.99%	(0.01) 75.00%	(-7.81) 75.00%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.85%	(0.01) 82.84%
FIIs	(-1.81) 5.08%	(0.41) 6.84%	(-0.21) 6.42%	(-0.21) 6.57%	(-1.11) 6.74%	(3.01) 7.85%	(-0.21) 4.81%	(0.41) 5.01%	(0.21) 4.57%	(1.11) 4.39%	(0.01) 3.27%	(-1.21) 3.28%	(-1.61) 4.45%	(-1.51) 6.04%	(-0.51) 7.58%	(-0.21) 8.12%	(0.31) 8.32%	(0.01) 8.03%
DIIs	(1.71) 7.13%	(-0.21) 5.47%	(0.41) 5.62%	(0.31) 5.19%	(0.71) 4.86%	(2.61) 4.16%	(0.21) 1.57%	(0.71) 1.41%	(0.11) 0.74%	(0.11) 0.64%	(0.61) 0.58%	(-0.11) 0.00%	(-0.71) 0.08%	(0.01) 0.79%	(0.21) 0.79%	(0.11) 0.56%	(0.01) 0.47%	(0.01) 0.46%
Public	12.89%	12.79%	13.03%	13.25%	13.40%	12.99%	10.76%	10.73%	11.84%	12.13%	13.30%	13.86%	12.62%	10.31%	8.78%	8.47%	8.36%	8.67%
No. of Shareholders	132,748	135,643	138,500	141,977	146,840	143,960	149,396	156,183	185,531	198,764	208,267	222,866	225,730	232,203	233,538	238,578	253,726	280,300

Quarterly Results

Profit and Loss

	Mar 2021	Mar 2020	Mar 2019
Sales	1885	1537	886
Sales Growth %	22.6%	73.4%	-
Expenses	1294	1065	639
Operating Profit	591	472	248
OPM %	31	31	28
Other Income	1	12	0
Interest	88	34	1
Depreciation	33	29	19
Profit before tax	471	421	228
Tax %	25	26	14
Net Profit	352	313	196
Net Profit Growth %	12.5%	59.7%	-
EPS in Rs	358.74	1597.37	997.86
Dividend Payout %	0	0	0

Cash Flows

	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	0	0	0
Cash from Investing Activity	0	0	0
Cash from Financing Activity	0	0	0
Net Cash Flow	0	0	0

Balance Sheet

	Mar 2021	Mar 2020	Mar 2019
Equity Capital	0	0	0
Reserves	0	0	0
Borrowings	0	0	0
Other Liabilities	0	0	0
Total Liabilities	0	0	0
Fixed Assets	0	0	0
CWIP	0	0	0
Investments	0	0	0
Other Assets	0	0	0
Total Assets	0	0	0

Delivery

Daily Market Cap

No records found.

Stock Checklist

Price is above from 52 week high low average: 47%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 10 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹999 Cr · 5 increasing / 5 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Axis Mutual Fund	6	0.90%	+0.66%	599.3
Aditya Birla Sun Life Mutual Fund	4	0.32%	-0.35%	399.6

Glenmark Life Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements